This assertion is identified by several observations: (1) JMJD2A inhibited P21(WAF1/Cip1) and enhanced Pim1 in liver cancer cell cycle progress through JMJD2AΔ dependent on miR372. The gene discussed is KDM4A; the disease is liver cancer.